These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32580113)

  • 1. A systematic review of opioid overdose interventions delivered within emergency departments.
    Chen Y; Wang Y; Nielsen S; Kuhn L; Lam T
    Drug Alcohol Depend; 2020 Aug; 213():108009. PubMed ID: 32580113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
    Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
    Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
    O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
    BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of patterns of opioid overdose and interventions delivered at a tertiary hospital emergency department: impact of COVID-19.
    Potaka KL; Freeman R; Soo D; Nguyen NA; Sim TF; Moullin JC
    BMC Emerg Med; 2022 Apr; 22(1):62. PubMed ID: 35397487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for Take-home naloxone In Multicentre Emergency (TIME) settings: feasibility study.
    Jones M; Bell F; Benger J; Black S; Buykx P; Dixon S; Driscoll T; Evans B; Edwards A; Fuller G; Goodacre S; Hoskins R; Hughes J; John A; Jones J; Moore C; Sampson F; Watkins A; Snooks H
    Pilot Feasibility Stud; 2020; 6():96. PubMed ID: 32670598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a take-home naloxone program at an urban academic emergency department.
    Eswaran V; Allen KC; Cruz DS; Lank PM; McCarthy DM; Kim HS
    J Am Pharm Assoc (2003); 2020; 60(6):e324-e331. PubMed ID: 32690447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yes, not now, or never: an analysis of reasons for refusing or accepting emergency department-based take-home naloxone.
    Kestler A; Giesler A; Buxton J; Meckling G; Lee M; Hunte G; Wilkins J; Marks D; Scheuermeyer F
    CJEM; 2019 Mar; 21(2):226-234. PubMed ID: 29789030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life after opioid-involved overdose: survivor narratives and their implications for ER/ED interventions.
    Elliott L; Bennett AS; Wolfson-Stofko B
    Addiction; 2019 Aug; 114(8):1379-1386. PubMed ID: 30851220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
    Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
    BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race, ethnicity, and emergency department post-overdose care.
    Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA
    J Subst Abuse Treat; 2021 Dec; 131():108588. PubMed ID: 34384652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of an opioid overdose prevention intervention delivered subsequent to acute care.
    Banta-Green CJ; Coffin PO; Merrill JO; Sears JM; Dunn C; Floyd AS; Whiteside LK; Yanez ND; Donovan DM
    Inj Prev; 2019 Jun; 25(3):191-198. PubMed ID: 29436397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhode Island's Opioid Overdose Hospital Standards and Emergency Department Naloxone Distribution, Behavioral Counseling, and Referral to Treatment.
    Samuels EA; Wentz A; McCormick M; McDonald JV; Marshall BDL; Friedman C; Koziol J; Alexander-Scott NE
    Ann Emerg Med; 2021 Jul; 78(1):68-79. PubMed ID: 33865617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone Administration in US Emergency Departments, 2000-2011.
    Frank JW; Levy C; Calcaterra SL; Hoppe JA; Binswanger IA
    J Med Toxicol; 2016 Jun; 12(2):148-56. PubMed ID: 26621354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a Peer-Led Behavioral Intervention for Emergency Department Patients at High Risk of Fatal Opioid Overdose: A Randomized Clinical Trial.
    Beaudoin FL; Jacka BP; Li Y; Samuels EA; Hallowell BD; Peachey AM; Newman RA; Daly MM; Langdon KJ; Marshall BDL
    JAMA Netw Open; 2022 Aug; 5(8):e2225582. PubMed ID: 35943744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
    Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
    Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
    Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
    J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.
    Drainoni ML; Koppelman EA; Feldman JA; Walley AY; Mitchell PM; Ellison J; Bernstein E
    BMC Res Notes; 2016 Oct; 9(1):465. PubMed ID: 27756427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the distribution of take-home naloxone in low- and middle-income countries and barriers to the implementation of take-home naloxone programs.
    Sajwani HS; Williams AV
    Harm Reduct J; 2022 Oct; 19(1):117. PubMed ID: 36266701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.